NO995459L - Vevsfaktor for påvirkning av blodkardannelse - Google Patents

Vevsfaktor for påvirkning av blodkardannelse

Info

Publication number
NO995459L
NO995459L NO995459A NO995459A NO995459L NO 995459 L NO995459 L NO 995459L NO 995459 A NO995459 A NO 995459A NO 995459 A NO995459 A NO 995459A NO 995459 L NO995459 L NO 995459L
Authority
NO
Norway
Prior art keywords
tissue factor
blood vessel
vessel formation
influencing blood
influencing
Prior art date
Application number
NO995459A
Other languages
English (en)
Norwegian (no)
Other versions
NO995459D0 (no
Inventor
Peter Nawroth
Katsumi Nakagawa
Youming Zhang
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of NO995459L publication Critical patent/NO995459L/no
Publication of NO995459D0 publication Critical patent/NO995459D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Instructional Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
NO995459A 1997-05-09 1999-11-08 Vevsfaktor for påvirkning av blodkardannelse NO995459D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19719652A DE19719652A1 (de) 1997-05-09 1997-05-09 Tissue-Faktor zur Förderung von Wundheilung
DEPCT/DE98/01278 1998-05-07
PCT/DE1998/001306 WO1998051321A1 (de) 1997-05-09 1998-05-08 Tissue-faktor zur beeinflussung von gefässbildung

Publications (2)

Publication Number Publication Date
NO995459L true NO995459L (no) 1999-11-08
NO995459D0 NO995459D0 (no) 1999-11-08

Family

ID=7829124

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995459A NO995459D0 (no) 1997-05-09 1999-11-08 Vevsfaktor for påvirkning av blodkardannelse

Country Status (16)

Country Link
EP (1) EP0980251B1 (is)
JP (1) JP2001527555A (is)
AT (1) ATE222501T1 (is)
AU (1) AU746782B2 (is)
CA (1) CA2288117A1 (is)
CZ (1) CZ293005B6 (is)
DE (2) DE19719652A1 (is)
DK (1) DK0980251T3 (is)
ES (1) ES2184299T3 (is)
HU (1) HUP0003831A3 (is)
IS (1) IS5231A (is)
NO (1) NO995459D0 (is)
PL (1) PL336662A1 (is)
PT (1) PT980251E (is)
SI (1) SI0980251T1 (is)
WO (1) WO1998051321A1 (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749498B2 (en) 1997-03-10 2010-07-06 Genentech, Inc. Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en) 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
US5986065A (en) 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20030109680A1 (en) 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
DE19719652A1 (de) * 1997-05-09 1998-12-03 Merckle Gmbh Tissue-Faktor zur Förderung von Wundheilung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
AU5093593A (en) * 1992-08-28 1994-03-29 Scripps Research Institute, The Inhibition of tumor metastasis via neutralization of tissue factor function
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
JPH10502534A (ja) * 1994-07-12 1998-03-10 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド 結合組織増殖因子−２
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
DE19719652A1 (de) * 1997-05-09 1998-12-03 Merckle Gmbh Tissue-Faktor zur Förderung von Wundheilung

Also Published As

Publication number Publication date
CZ391299A3 (cs) 2000-04-12
ATE222501T1 (de) 2002-09-15
DE19719652A1 (de) 1998-12-03
AU746782B2 (en) 2002-05-02
ES2184299T3 (es) 2003-04-01
HUP0003831A3 (en) 2003-08-28
EP0980251B1 (de) 2002-08-21
CZ293005B6 (cs) 2004-01-14
PT980251E (pt) 2003-01-31
PL336662A1 (en) 2000-07-03
EP0980251A1 (de) 2000-02-23
SI0980251T1 (en) 2003-02-28
HUP0003831A2 (hu) 2001-02-28
JP2001527555A (ja) 2001-12-25
WO1998051321A9 (de) 1999-04-01
DE59805246D1 (de) 2002-09-26
WO1998051321A1 (de) 1998-11-19
IS5231A (is) 1999-10-26
DK0980251T3 (da) 2002-11-18
NO995459D0 (no) 1999-11-08
AU8331598A (en) 1998-12-08
CA2288117A1 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DE69634519D1 (de) Katheter zur ablation von atrio-ventikulären gewebe
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
DE69827192D1 (de) Stent und Stent-Transplantat zur Behandlung von verzweigten Blutgefässen
NO944997L (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE60028863D1 (de) Elektrochirurgisches Handstück zur Behandlung von Gewebe
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
DE69617963D1 (de) Behandlung von titandioxidaufachlämmungen mittels scherkräften
EP0651655A4 (en) REDUCTION OF MICROVASCULAR BLEEDING DURING SURGERY BY BLOCKING PROTEIN C ACTIVATION
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
NO995459L (no) Vevsfaktor for påvirkning av blodkardannelse
DE3772051D1 (de) Prothese zur expansion des hautgewebes.
NO984965D0 (no) Komponent B som cicatrisant
DE69832075D1 (de) Verwendung von eprosartan zur behandlung von isoliertem systolischem bluthochdrucks
UA32315A (uk) Спосіб накладання шкірного шва
ATE94759T1 (de) Verwendung von dextransulfat, gegebenenfalls in kombination mit anti-androgenen mitteln zur behandlung des humanen protatakarzinoms.
DE50000676D1 (de) Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation zur behandlung von pankreatitis
DE69912778D1 (de) Verwendung von wundverbänden zur behandlung von akuten wunden
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE60043024D1 (de) Elektrochirurgisches Handstück zur Behandlung von Gewebe
LV11523A (lv) Domperidona pielietosana kardalgijas arstesana

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application